An innovative new treatment for T-cell lymphoma (TCL) is one step closer to reaching clinical trials.
Proceeds will enable the initiation of the pivotal clinical trial RESTORE.
Cleveland Clinic Innovations prides itself on fostering new ways to advance patient care.